US Patent 7923011 Antibodies to lymphotoxin-alpha
Patent 7923011 was granted and assigned to Genentech on April, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
The invention provides various antibodies that bind to lymphotoxin-α, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Austin L. Gurney0
Camellia W. Adams0
Jane L. Grogan0
Krista McCutcheon0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07923011 Antibodies to lymphotoxin-alpha US Patent 7923011 Antibodies to lymphotoxin-alpha
Infobox
Patent Number
079230110
Patent Number
79230110
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079230110
Date of Patent
April 12, 2011
0Patent Application Number
118711360
Date Filed
October 11, 2007
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07923011 Antibodies to lymphotoxin-alpha
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07923011
Date of patent
April 12, 2011
Patent application number
11871136
Date Filed
October 11, 2007
Patent primary examiner
Find more entities like US Patent 7923011 Antibodies to lymphotoxin-alpha
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
